Cite
HARVARD Citation
Thivalapill, N. et al. (2021). Transition to Dolutegravir Is Associated With an Increase in the Rate of Body Mass Index Change in a Cohort of Virally Suppressed Adolescents. Clinical infectious diseases. pp. e580-e586. [Online].